FDA NDC Directory · JSON-LD · Markdown

NUZOLVENCE

NDC 68547-915 · HUMAN PRESCRIPTION DRUG · FOR SUSPENSION

Generic namezoliflodacin
Labeler / ManufacturerLa Jolla Pharmaceutical Company
Marketing categoryNew Drug Application (innovator) · App NDA219491
Dosage form / routeFOR SUSPENSION · ORAL
Active ingredientsZOLIFLODACIN (3 g/1)
Marketing started20260401
Package count1

External sources

Source: openFDA. Public-domain (CC0).